CAS
|
29094-61-9
|
中文名称
|
格列吡嗪
|
英文名称
|
Glipizide
|
别名
|
格列甲嗪
|
纯度
|
HPLC≥98%
|
分子式
|
C21H27N5O4S
|
分子量
|
445.54
|
外观(性状)
|
White to off-white Solid
|
储存条件
|
Powder : 2-8℃, 2 years; In solvent(母液): -20℃, 1 month; -80℃, 6 months
|
溶解性
|
Soluble in DMSO ≥10mg/mL
|
MDL
|
MFCD00072159
|
EC
|
EINECS 249-427-6
|
InChIKey
|
ZJJXGWJIGJFDTL-UHFFFAOYSA-N
|
InChI
|
InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)
|
PubChem CID
|
3478
|
SMILES
|
O=C(C1=NC=C(C)N=C1)NCCC2=CC=C(S(=O)(NC(NC3CCCCC3)=O)=O)C=C2
|
描述
|
(It is an effective sulfonylurea reagent for experimental research in type 2 diabetes.)
|
靶点
|
Potassium Channel
|
通路
|
Membrane Transporter&Ion Channel
|
规格
|
50mg 100mg 10mM*1mL (in DMSO)
|
单位
|
瓶
|